What are you looking for?
By Mario Nacinovich The US Food and Drug Administration (FDA) is requiring every application holder for a glucagon-like peptide-1 receptor agonist (GLP-1 RA) to add language to the Warnings and Precautions section of labeling describing a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), according to a Drug Safety Communication issued November 9, 2026.... ...
Harrow has launched HarrowRx, a prescribing and pharmacy access platform that allows eyecare professionals to prescribe the company’s full portfolio of branded...
A study published in the Journal of Optometry found that over half of optometrists are showing signs of burnout. Kaleb Abbott, OD,...
Bausch + Lomb Corporation announced the acquisition of Trukera Medical, a United States-based ophthalmic medical diagnostic company, according to a press release....
By Mario Nacinovich The US Food and Drug Administration (FDA) is requiring every application holder for a glucagon-like peptide-1 receptor agonist (GLP-1 RA) to add language to the Warnings and...
Harrow has launched HarrowRx, a prescribing and pharmacy access platform that allows eyecare professionals to prescribe the company’s full portfolio of branded products directly through their existing electronic medical record... ...
A study published in the Journal of Optometry found that over half of optometrists are showing signs of burnout. Kaleb Abbott, OD, an optometrist and assistant professor at the University...
Bausch + Lomb Corporation announced the acquisition of Trukera Medical, a United States-based ophthalmic medical diagnostic company, according to a press release. Trukera Medical, previously owned by AccelMed Partners and...